Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat

Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to l-DOPA in the hemi-parkinsonian rat

(2014) Corinne Y. Ostock et al.   BEHAVIOURAL BRAIN RESEARCH

Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease

(2014) Eunju Shin et al.   EXPERIMENTAL NEUROLOGY

L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum

(2014) Yong Wang et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease

(2013) Susan H. Fox   DRUGS

The effects of BMY-14802 against l-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat

(2013) Nirmal Bhide et al.   PSYCHOPHARMACOLOGY

Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study)

(2012) P. A. LeWitt et al.   NEUROLOGY

Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats

(2011) Kristin B. Dupre et al.   EXPERIMENTAL NEUROLOGY

Behavioral and Cellular Modulation of L-DOPA-Induced Dyskinesia by  -Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat

(2011) D. Lindenbach et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats

(2011) Christopher J. Barnum et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

The locus coeruleus Is Directly Implicated in L-DOPA-Induced Dyskinesia in Parkinsonian Rats: An Electrophysiological and Behavioural Study

(2011) Cristina Miguelez et al.   PLoS One

Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons

(2010) Masato Hara et al.   JOURNAL OF NEUROCHEMISTRY

β1-Adrenergic receptors activate two distinct signaling pathways in striatal neurons

(2010) John Meitzen et al.   JOURNAL OF NEUROCHEMISTRY

The α2adrenoceptor antagonist idazoxan alleviates l-DOPA-induced dyskinesia by reduction of striatal dopamine levels: anin vivomicrodialysis study in 6-hydroxydopamine-lesioned rats

(2009) Kerstin Buck et al.   JOURNAL OF NEUROCHEMISTRY

l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson’s disease: temporal and quantitative relationship to the expression of dyskinesia

(2009) Hanna S. Lindgren et al.   JOURNAL OF NEUROCHEMISTRY

Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats

(2009) Christopher Bishop et al.   JOURNAL OF NEUROSCIENCE RESEARCH

The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats

(2009) Karen L. Eskow et al.   SYNAPSE

The selective α1adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease

(2009) Kerstin Buck et al.   SYNAPSE

Reuptake ofL-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter

(2008) Akira Arai et al.   SYNAPSE